FCX vs OCUL · P/E 38, rev $25.45B vs rev $63.7M
Freeport-McMoran Copper & Gold Inc (FCX) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the FCX and OCUL stock pages for the full models.
Not investment advice.